Dr. Lingxiao Zhang received his PhD in 2020 and then served as a research assistant professor and tenured associate professor at Zhejiang University. He joined Aarhus University in 2023 and has been serving as a Marie Sklodowska-Curie Actions Research Fellow. His research focuses on the controllable preparation of next-generation nano-aluminum adjuvant (NanoAlum) for cancer immunotherapy, inflammation treatment, and neurodegenerative disease therapy. Up till now, he has published over 44 peer-reviewed articles in Advanced Materials, Acta Pharmaceutica Sinica B, Advanced Science, Advanced Functional Materials, ACS Nano, Advanced Drug Delivery Reviews, Journal of Controlled Release, and Biomaterials etc. He also serves as an editor for Journal of Nanobiotechnology. He is an editor of Chinese Chemical Letters, Journal of Nanobiotechnology, and Exploration, and also serves as an editorial board member of 9 journals including Asian Journal of Pharmaceutical Sciences, Nano-Micro Letters, and Microstructures.